Back to Journals » OncoTargets and Therapy » Volume 8

The human immunodeficiency virus protease inhibitor ritonavir is potentially active against urological malignancies

Total article views   Abstract views HTML views PDF downloads Totals
8,204 Dovepress* 4,880 2,798+ 1,462 7,678
PubMed Central* 0 526 138 526
Totals 4,880 3,324 1,600 8,204
*Since 8 April 2015
+Since July 2016

View citations on PubMed Central and Google Scholar